Stay updated on Risankizumab Autoinjector Usability Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.

Latest updates to the Risankizumab Autoinjector Usability Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal regarding a study on the usability and efficacy of the risankizumab autoinjector for treating moderate to severe plaque psoriasis, while a new version number has been added.SummaryDifference10%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to Risankizumab Autoinjector Usability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.